Anthracyclines in the treatment of HER2-negative breast cancer.
Paik
Soonmyung
S
Taniyama
Yusuke
Y
Geyer
Charles E
CE
D018943:Anthracyclines / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
D018943:Anthracyclines; D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases